- Home
- HAFC vs ORGO Comparison
HAFC vs ORGO Comparison
Compare HAFC & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAFC
- ORGO
- Stock Information
- Founded
- HAFC 1982
- ORGO 1985
- Country
- HAFC United States
- ORGO United States
- Employees
- HAFC N/A
- ORGO N/A
- Industry
- HAFC Major Banks
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- HAFC Finance
- ORGO Health Care
- Exchange
- HAFC Nasdaq
- ORGO Nasdaq
- Market Cap
- HAFC 758.9M
- ORGO 620.3M
- IPO Year
- HAFC 1996
- ORGO N/A
- Fundamental
- Price
- HAFC $23.30
- ORGO $4.04
- Analyst Decision
- HAFC Buy
- ORGO Buy
- Analyst Count
- HAFC 6
- ORGO 3
- Target Price
- HAFC $26.00
- ORGO $7.33
- AVG Volume (30 Days)
- HAFC 126.8K
- ORGO 769.1K
- Earning Date
- HAFC 10-21-2025
- ORGO 11-06-2025
- Dividend Yield
- HAFC 4.63%
- ORGO N/A
- EPS Growth
- HAFC N/A
- ORGO N/A
- EPS
- HAFC 2.16
- ORGO N/A
- Revenue
- HAFC $233,739,000.00
- ORGO $429,531,000.00
- Revenue This Year
- HAFC $17.24
- ORGO $2.51
- Revenue Next Year
- HAFC $7.86
- ORGO $25.45
- P/E Ratio
- HAFC $10.79
- ORGO N/A
- Revenue Growth
- HAFC N/A
- ORGO N/A
- 52 Week Low
- HAFC $19.25
- ORGO $2.61
- 52 Week High
- HAFC $27.59
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- HAFC 38.44
- ORGO 39.12
- Support Level
- HAFC $22.85
- ORGO $3.84
- Resistance Level
- HAFC $25.01
- ORGO $4.21
- Average True Range (ATR)
- HAFC 0.68
- ORGO 0.17
- MACD
- HAFC -0.17
- ORGO -0.01
- Stochastic Oscillator
- HAFC 17.65
- ORGO 33.04
About HAFC Hanmi Financial Corporation
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.